The incidence increases again this Friday, registering 44.49 cases per 100,000 inhabitants. It is the third consecutive day that the curve has experienced a rise, although since Thursday of last week there have been slight decreases and increases.
By age groups, the stratum with the lowest incidence is that of people between 12 and 19 years old, with 28.36 cases per 100,000 inhabitants, while young people between 20 and 29 years old register an increase in the incidence rate, which stands at 41.38 cases.
The Ministry of Health has notified 2,556 new infections, while this Thursday 1,881 new cases of COVID-19 were registered. In total, since the coronavirus emergency situation began, 4,997,732 people have been infected in Spain.
Catalunya, with 580 positives; Madrid, which adds 430; and Euskadi, with 312 are the communities that reported the most infections this Friday.
Saturation in hospitals continues with a downward trend, with 1,730 people hospitalized and a bed occupancy rate by COVID patients of 1.41%, lower than this Thursday.
In addition, Health has reported 30 deaths, an increase compared to this Thursday, when 20 deaths were registered. The total death toll since the pandemic began now stands at 87,132 people.
78.4% of the Spanish population already has the complete guideline against COVID-19
The Ministry of Health has notified that 78.4% of the population in Spain already has the complete vaccination schedule against COVID-19, a total of 37,199,581 people. On the other hand, 80% have at least one anti-COVID dose.
By age group, 81.7% of people between 12 and 19 years old, who started the immunization campaign in summer, have the maximum protection against the coronavirus, while almost 85% of this stratum have at least an injection.
The experts of the Ministry of Health propose an extra dose for the almost two million vaccinated with Janssen
The Vaccine Conference, made up of experts who advise the Ministry of Health, will propose to the Public Health Commission that a booster dose of Pfizer or Moderna be injected to the nearly two million people who received the Janssen single-dose serum after verifying a reduction in protection, as confirmed by the department headed by Carolina Darias. "The presentation values its incorporation into the strategy," says a spokeswoman, who assures that it is "in a constant review process."
However, the decision, to be final, must be approved by the Public Health Commission. The autonomous communities hope that this step will be taken next week, although some already knew "informally" that the booster dose for the 1.9 million vaccinated with Janssen was going to arrive sooner rather than later. The initial idea is that the injection is administered at least three months after the first and that it always be of messenger RNA, that is, the pattern would be heterologous (two different vaccines).